Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in the Treatment of Chronic Hepatitis B

Clinical trial NCT07282249 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07282249
Sponsor: Grand Theravac Life Sciences (Nanjing) Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic hepatitisB

Start date: 2025-12-31
Primary completion: 2027-04-30
Enrollment: 630

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.